"Mills-Peninsula Medical Center provides emergency services, surgery, radiology, nuclear medicine, cardiovascular, neurology, intensive care, respiratory, labor and delivery, and both inpatient and outpatient services to the Burlingame community.The Joint Commission recognizes this hospital as a Primary Stroke Center for their exceptional ability to provide high-quality stroke care."

During the past decade, Mills-Peninsula Medical Center conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 105 clinical trials were completed, i.e. on average, 129.6% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 63 clinical trials were completed. i.e. 393.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mills-Peninsula Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 74 trials, followed by "SWOG Cancer Research Network" with 48 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Radiation Therapy Oncology Group" with 10 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mills-Peninsula Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "Canadian Cancer Trials Group" with 8 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Mills-Peninsula Medical Center" are "Breast Cancer" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Invasive Breast Carcinoma" (7 trials). Many other conditions were trialed in "Mills-Peninsula Medical Center" in a lesser frequency.

Most popular intervention types in "Mills-Peninsula Medical Center" are "Drug" (145 trials), "Other" (107 trials), "Biological" (72 trials), "Radiation" (36 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (66 trials), "Quality-of-Life Assessment" (34 trials), "Bevacizumab" (20 trials), "Paclitaxel" (18 trials) and "Cisplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Mills-Peninsula Medical Center" are 140 trials for "All" genders, 42 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Mills-Peninsula Medical Center". undefined are not yet recruiting, 20 are recruiting, 80 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Mills-Peninsula Medical Center, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Mills-Peninsula Medical Center, 4 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".